ARDELYX, INC. Investments and Cash
ARDELYX, INC. (ARDX) had Investments and Cash of $281.83 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2026-08-06
- 2026-06-30: Investments and Cash $281.83M.
- 2026-03-31: Investments and Cash $238.07M.
- 2025-12-31: Investments and Cash $264.69M.
- 2025-09-30: Investments and Cash $242.71M.
| Period end | Investments and Cash | Investments and Cash as first filed |
|---|---|---|
| 2026-06-30 | $281.83M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $238.07M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $264.69M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $242.71M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $238.45M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $213.95M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $250.10M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $190.40M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $185.96M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $202.58M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $184.30M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $165.08M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $127.58M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $130.37M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $123.91M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $90.62M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $81.01M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $89.70M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $116.69M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $141.65M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $171.80M 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $188.60M 10-K · filed 2022-02-28 | $188.60M 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |